Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer

被引:0
|
作者
Li, Cong [1 ]
Zhu, Yongzhi [2 ]
Shi, Song [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Otorhinolaryngol, Shanghai 200336, Peoples R China
[2] Zhengzhou Shuqing Med Coll, Zhengzhou, Peoples R China
关键词
Cuproptosis; Risk model; Prognosis; Laryngeal cancer; Immune; CELL; TMEM2;
D O I
10.1016/j.bjorl.2023.101384
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Laryngeal cancer, characterized by high recurrence rates and a lack of effective biomarkers, has been associated with cuproptosis, a regulated cell death process linked to cancer progression. In this study, we aimed to explore the roles of cuproptosis-related genes in laryngeal cancer and their potential as prognostic markers and therapeutic targets. Methods: We collected comprehensive data from The Cancer Genome Atlas and Gene Expression Omnibus databases, including gene expression profiles and clinical data of laryngeal cancer patients. Using clustering and gene analysis, we identified cuproptosis-related genes with prognostic significance. A risk model was constructed based on these genes, categorizing patients into high- and low -risk groups for outcome comparison. Univariate and multivariate analyses were conducted to identify independent prognostic factors, which were then incorporated into a nomogram. Gene Set Enrichment Analysis was employed to explore pathways distinguishing high- and low -risk groups. Results: Our risk model, based on four genes, including transmembrane 2, dishevelled binding antagonist of B-catenin 1, stathmin 2, and G protein -coupled receptor 173, revealed significant differences in patient outcomes between high- and low -risk groups. Independent prognostic factors were identified and integrated into a nomogram, providing a valuable tool for prognostic prediction. Gene Set Enrichment Analysis uncovered up -regulated pathways specifically associated with high -risk patient samples. Conclusion: This study highlights the potential of cuproptosis-related genes as valuable prognostic markers and promising therapeutic targets in the context of laryngeal cancer. This research sheds light on new avenues for understanding and managing this challenging disease. Level of evidence: Level 4. (c) 2023 Associacao Brasileira de Otorrinolaringologia e Cirurgia C ' ervico-Facial. Published by Elsevier Espan similar to a, S.L.U. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Cuproptosis-Related Genes as Prognostic Biomarkers for Sepsis: Insights into Immune Function and Personalized Immunotherapy
    Zhang, Jun
    Wu, Yinyu
    Du, Yuanlin
    Du, Yunxia
    Bao, Daiqin
    Lu, Haibin
    Zhou, Xiaoqiong
    Li, Rui
    Pei, Haoyu
    She, Han
    Mao, Qingxiang
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17
  • [42] A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes
    Liang, Pengchen
    Chen, Jianguo
    Yao, Lei
    Hao, Zezhou
    Chang, Qing
    BIOMEDICINES, 2023, 11 (05)
  • [43] Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer
    Chen, Jian
    Cao, Wei
    Li, Yingliang
    Zhu, Jia
    MEDICINE, 2024, 103 (42)
  • [44] Identification of Cuproptosis-Related Genes for Molecular Subtyping: Predicting Prognostic and Therapeutic Response in Glioma
    Xia, Xiaochun
    Huang, Xiaoying
    Wu, Longxiang
    Xu, Pengqin
    Li, Peng
    ONCOTARGETS AND THERAPY, 2024, 17 : 1069 - 1088
  • [45] Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
    Zhou, Zheng
    Zhou, Yusong
    Liu, Dongbo
    Yang, Qingping
    Tang, Mengjie
    Liu, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
    Yuqiao Chen
    Lu Tang
    Wentao Huang
    Fakolade Hannah Abisola
    Youyu Zhang
    Gewen Zhang
    Lei Yao
    Biology Direct, 18
  • [47] A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
    Hou, Dong
    Tan, Jia-nan
    Zhou, Sheng-ning
    Yang, Xu
    Zhang, Zhi-hong
    Zhong, Guang-yu
    Zhong, Lin
    Yang, Bin
    Han, Fang-hai
    FRONTIERS IN GENETICS, 2022, 13
  • [48] Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
    Zhou, Min
    Tang, Jianming
    Huang, Guotao
    Hong, Li
    BIOMEDICINES, 2024, 12 (11)
  • [49] A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
    Xu, Qi-Tong
    Wang, Zi-Wen
    Cai, Meng-Yuan
    Wei, Ji-Fu
    Ding, Qiang
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [50] Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
    Zhang, Li
    Xu, Jingwei
    Chu, Xiufeng
    Zhang, Hongqiao
    Yao, Xueyuan
    Zhang, Jian
    Guo, Yanwei
    BMC BIOINFORMATICS, 2022, 23 (01)